基质金属蛋白酶-2、血管内皮生长因子、血小板活化因子对腹水性质的诊断价值
出处
《临床肝胆病杂志》
CAS
2008年第6期460-462,共3页
Journal of Clinical Hepatology
参考文献26
-
1Elsharkawy AM, Oakley F, Mann DA. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis[ J]. Apoptosis. 2005,10(5 ) : 927 -39.
-
2Liu HL,Li XH,Wang DY,Yang SP.Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 expression in fibrotic rat liver[J].World Journal of Gastroenterology,2000,6(6):881-884. 被引量：31
-
3Curran S, Murray GI. Matrix metalloproteinase : molecular aspects of their roles in tumor invasion and metastasis[ J]. Eur J Cancer, 2000, 36:1621 - 1630.
-
4Waas ET, Lomme RM, DeGroot J, et al. Tissue levels of active matrix metalloproteinase -2 and 9 in colorectal cancer[ J]. Br J Cancer, 2002, 86:1876 - 1883.
-
5Kleiner DE, Stetler - Stevenson WG. Matrix metalloproteinases and metastasis[J]. Cancer Chemother Pharmacol, 1999, 43 (Suppl) : S42 -51.
-
6Ji F,Wang WL,Yang ZL,Li YM,Huang HD,Chen WD.Study on the expression of matrix metalloproteinase-2 mRNA in human gastric cancer[J].World Journal of Gastroenterology,1999,5(5):455-457. 被引量：19
-
7蒋泽生,高毅.基质金属蛋白酶的生物学特性及其在肝癌浸润转移中的作用[J].世界华人消化杂志,2000,8(12):1403-1404. 被引量：14
-
8Ellenrieder V, Alber B, Lacher U, et al. Role of MT - MMPs and MMP- 2 in pancreatic cancer progression [ J J. Int J Cancer, 2000, 85:14 -20.
-
9Huhtala P, Chow LT, Tryggvason K. Structure of the human type Ⅳ collagenase gene[J]. J Biol Chem, 1990, 265:1107 -1108.
-
10孙晓敏,董卫国,余保平,罗和生,于皆平.恶性腹水基质金属蛋白酶活性分析[J].世界华人消化杂志,2004,12(2):376-378. 被引量：11
二级参考文献62
-
1高芸,李新娜,李少一,宗志宏,王学荣,于秉治.脑肿瘤患者脑脊液中基质金属蛋白酶活性表达的研究[J].中国医科大学学报,2000,29(S1):13-14. 被引量：2
-
2DU Wei-Dong,ZHANG Yue-E,ZHAl Wei-Rong and ZHOU Xiao-Mei(Department of Pathology, Shanghai Medical University, Shanghai200032, China)(National Laboratory for Oncogenes and Related Genes, ShanghaiCencer Institute)See invited commentary on page 388.Dynamic changes of typeⅠ,Ⅲand N collagen synthesis and distribution of collagen-producing cells in carbon tetrachloride-induced rat liver fibrosis[J].World Journal of Gastroenterology,1999,5(5):397-403. 被引量：47
-
3Ji F,Wang WL,Yang ZL,Li YM,Huang HD,Chen WD.Study on the expression of matrix metalloproteinase-2 mRNA in human gastric cancer[J].World Journal of Gastroenterology,1999,5(5):455-457. 被引量：19
-
4张帆，中华医学杂志，1990年，70卷，375页
-
5李平，上海免疫学杂志，1985年，5卷，39页
-
6Imoto H, Osakl T, Taga S, et al. Vascular eadothelial growth factor expression iu non-small-cell lung cancer: Prognostic signficance in squamous cell carcinoma[ J ]. J Thoracic Cardiovasc Surdiovasc Surgery,1998,115 (10) :1007-1014.
-
7Kraft A,Weindel K,Ochs A,et al. Vascular endothelial growth factor in the sera and effusion of patients with malignant and nonmalignant disease[J]. Cancer, 1999,85(1 ) :178-187.
-
8Mori A,Arii S, Furutani M, et al. Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes[ J ]. Gene Therapy,2000,7(12): 1027-1033.
-
9Zebrowski BK,Liu W,Ramirez K,et al. Markedly elevated levels of vascular endothelial growth factor in malignant ascites[ J]. Ann Sury Onco1,1999,6 (4) :373-378.
-
10Stoelcker B,Ehtenacher B, Weich HA. VEGF/Flk-1 interaction a reqirement for malignt aseites recurrence[ J].J Interfer Cyto Res,2000,20(4) :511-517.
共引文献73
-
1王宇,贾继东.已酮可可碱的抗肝纤维作用及其机制[J].临床肝胆病杂志,2007,23(3):230-232. 被引量：1
-
2Li Hou Ying Li Yong-Hua Jia Bo Wang Yi Xin Mao-Ying Ling Shen Lü Department of Pathology,Dalian Medical University,Dalian 116027,Liaoning Province,ChinaDepartment of Biochemistry,Dalian Medical University,Dalian 116027,Liaoning Province,China.Molecular mechanism about lymphogenous metastasis of hepatocarcinoma cells in mice[J].World Journal of Gastroenterology,2001,7(4):532-536. 被引量：47
-
3Ping-Sheng Chen~(1,2) Wei-Rong Zhai~1 Xiao-Mei Zhou~3 Jin-Sheng Zhang~1 Yue-E Zhang~1 Yu-Qin Ling~1 Ying-Hong Gu~1 1 Department of Pathology,School of Basic Medical Sciences,Fudan University,Shanghai 200032,China2 Ping-Sheng Chen now works in the Department of Pathology,School of Basic Medical Sciences the (former Nanjing Railway Medical College),Southeast University,Nanjing 210009,China3 Institute of Cancer Research,Shanghai 200032,China.Effects of hypoxia,hyperoxia on the regulation of expression and activity of matrix metalloproteinase-2 in hepatic stellate cells[J].World Journal of Gastroenterology,2001,7(5):647-651. 被引量：18
-
4范跃祖,张景涛.金属蛋白酶-2及其组织抑制因子在原发性胆囊癌的表达及意义(英文)[J].外科研究与新技术,2004(2):144-151.
-
5张惠忠,吕志强,谢德荣,李海刚,熊利华,张华,陈晓兵.COX-2和MMP-2蛋白的表达对肺癌预后的影响[J].癌症,2004,23(10):1190-1193. 被引量：1
-
6范玉晶,韩明子.基质金属蛋白酶和消化道肿瘤的相关性[J].世界华人消化杂志,2004,12(9):2174-2176. 被引量：11
-
7刘兰芳,杜新生,李燕,赵晓明,高继红.Cox-2、VEGF在乳腺癌中的研究进展[J].承德医学院学报,2005,22(1):65-68. 被引量：1
-
8Wei-DaZheng Li-JuanZhang Mei-NaShi Zhi-XinChen Yun-XinChen Yue-HongHuang Xiao-ZhongWang.Expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in hepatic stellate cells during rat hepatic fibrosis and its intervention by IL-10[J].World Journal of Gastroenterology,2005,11(12):1753-1758. 被引量：35
-
9韩明子,范玉晶,王双双.基质金属蛋白酶-2,-9及铁蛋白对鉴别良恶性腹水的意义[J].世界华人消化杂志,2005,13(7):927-928. 被引量：5
-
10张建东,张育,顾健,沈维干,程宏.三氧化二砷对K562细胞基质金属蛋白酶-2、9活性的影响[J].实用临床医药杂志,2005,9(7):26-28. 被引量：3
-
1高君婷,杨帆,李伟峰.手术创伤和外科体液特点[J].中华综合临床医学杂志（北京）,2004,6(1):143-144.
-
2李昌艳,方伟.人乳腺癌组织中血小板活化因子的表达及临床意义[J].中华实验外科杂志,2009,26(12):1716-1717. 被引量：1
-
3周业庭,杨继武,杨叶洋,钱建民.人肝癌组织中血小板活化因子的表达及其临床意义[J].中华实验外科杂志,2009,26(9):1142-1143.
-
4李运泽.恶性腹水的实验室诊断现状与进展[J].广西医学,2003,25(3):398-400. 被引量：2
-
5李启祥.端粒酶活性对良性和恶性腹水的鉴别诊断价值[J].湖北民族学院学报（医学版）,2002,19(3):12-14.
-
6张桂凡.胆囊壁声像图改变在鉴别腹水性质中的价值探讨[J].中国社区医师（医学专业）,2005,7(20):47-47. 被引量：1
-
7李荣萍,张芳,刘峰,任佳,吕文静,焦巳彧.局部中晚期乳腺癌中血小板活化因子的表达及意义[J].武警后勤学院学报（医学版）,2013,22(11):969-971.
-
8刘锦,李贵新,路中,孙秀梅,马长庚,魏素臻.VEGF、HIF-1α在恶性腹水中的表达及临床意义[J].山东医药,2009,49(7):70-71. 被引量：1
-
9谢春英.非胆囊性病变胆囊壁声像图改变对腹水性质的鉴别价值初探[J].实用医技杂志,2002,9(3):178-179. 被引量：1
-
10刘康海.实验室检查对鉴别良恶性腹水的价值[J].广西医学,2002,24(3):374-376.
